Qualigen Therapeutics Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Qualigen Therapeutics Stock Summary

Qualigen Therapeutics competes with ZyVersa Therapeutics, Immix Biopharma, Phio Pharmaceuticals, 180 Life, and Entera Bio. Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California. Qualigen Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs people.

Qualigen Therapeutics Key Financial Ratios

Qualigen Therapeutics Key Balance Sheet Accounts

Qualigen Therapeutics Key Income Statement Accounts

Qualigen Therapeutics Key Cash Accounts

Qualigen Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Qualigen Therapeutics's current stock value. Our valuation model uses many indicators to compare Qualigen Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Qualigen Therapeutics competition to find correlations between indicators driving Qualigen Therapeutics's intrinsic value. More Info.Qualigen Therapeutics is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Qualigen Therapeutics' Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Qualigen Therapeutics' earnings, one of the primary drivers of an investment's value.

Qualigen Therapeutics Systematic Risk

Today, most investors in Qualigen Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Qualigen Therapeutics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Qualigen Therapeutics growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Qualigen Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Qualigen Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Qualigen Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Qualigen Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Qualigen Therapeutics's daily price indicators and compare them against related drivers.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Qualigen Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in Qualigen Stock, please use our How to Invest in Qualigen Therapeutics guide.You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Qualigen Therapeutics. If investors know Qualigen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Qualigen Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Qualigen Therapeutics is measured differently than its book value, which is the value of Qualigen that is recorded on the company's balance sheet. Investors also form their own opinion of Qualigen Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Qualigen Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Qualigen Therapeutics' market value can be influenced by many factors that don't directly affect Qualigen Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Qualigen Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Qualigen Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Qualigen Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.